Intervention Review

Low dose naltrexone for induction of remission in Crohn's disease

  1. Dan Segal1,
  2. John K MacDonald2,
  3. Nilesh Chande3,*

Editorial Group: Cochrane Inflammatory Bowel Disease and Functional Bowel Disorders Group

Published Online: 21 FEB 2014

Assessed as up-to-date: 28 FEB 2013

DOI: 10.1002/14651858.CD010410.pub2


How to Cite

Segal D, MacDonald JK, Chande N. Low dose naltrexone for induction of remission in Crohn's disease. Cochrane Database of Systematic Reviews 2014, Issue 2. Art. No.: CD010410. DOI: 10.1002/14651858.CD010410.pub2.

Author Information

  1. 1

    London Health Sciences Centre - University Hospital, London, Ontario, Canada

  2. 2

    Robarts Research Institute, Robarts Clinical Trials, London, Ontario, Canada

  3. 3

    London Health Sciences Centre - Victoria Hospital, London, Ontario, Canada

*Nilesh Chande, London Health Sciences Centre - Victoria Hospital, Room E6-321A, 800 Commissioners Road East, London, Ontario, N6A 5W9, Canada. nilesh.chande@lhsc.on.ca. nchande2@uwo.ca.

Publication History

  1. Publication Status: New
  2. Published Online: 21 FEB 2014

SEARCH

  1. Current Version

    Low dose naltrexone for induction of remission in Crohn's disease

    Dan Segal, John K MacDonald and Nilesh Chande

    Article first published online: 21 FEB 2014 | DOI: 10.1002/14651858.CD010410.pub2

Previous versions of this article and their online publication dates

  1. You have free access to this content

    Version 1

    Low dose naltrexone for induction of remission in Crohn's disease

    Dan Segal, John K MacDonald and Nilesh Chande

    Article first published online: 28 FEB 2013 | DOI: 10.1002/14651858.CD010410